Peer Review History
| Original SubmissionJanuary 15, 2020 |
|---|
|
PONE-D-20-01313 Decomposition of arbitrary sets of distributions in extended exponential family form for distinguishing multiple expression profiles of single-cell populations and visualizing their dynamics PLOS ONE Dear Prof. Yamada, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Mar 20 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Alan D Hutson Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf Additional Editor Comments (if provided): Please attend to the major concerns of both reviewers. If these concerns are not addressed this manuscript will not be processed further. As noted by both reviewers there is strong potential for your methods, but there needs to be some additional non-trivial work prior to publication. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this work, the authors proposed an interesting method (DEEF) for the decomposition of a set of exponential family distributions. The method makes use of the property of the inner product of extended exponential families (EEFs) and translates the decomposition of distributions into that of EEF parameters, which can be carried out by a standard spectral decomposition approach. The theoretical properties have been well discussed. The authors proposed the application of DEEF in the study of the expression profiles of single-cell populations, and it was demonstrated using a cytometry data set with four selected markers. The manuscript is mostly well written. Implementation has been shared online. However, I have a major concern regarding the proposed method and some minor comments. Major comment (1) High-dimensional single cell measurements are becoming increasingly common, such as CyTOF and single cell RNA-seq. The authors have discussed application in multi-omics. However, the proposed method relies on estimating the probability mass on a grid of the sample space through kNN or kernel density estimation. This will be quite difficult for high-dimensional settings for several reasons: 1. the number of grids grows exponentially with the dimensionality; 2. local methods such as kNN do not work well in high dimensional settings; 3. It is hard to select the parameters such as k and bandwidth. Therefore, I think the proposed method will have limited application for more recent single cell expression data. I recommend the authors demonstrate its application in a dataset with larger number of variables. Minor comments (2) Please elaborate on the interpretation of theta space. While it has been explained that the theta space is obtained by decomposition of n distributions, the authors can comment more on the relationship between theta space and the original parameters, and distinguish them by notations. (3) The authors have shared the implementation on GitHub with an example starting from the probability mass matrix. It would be more helpful if the authors can provide the original data and include the code for obtaining the probability mass matrix. (4) Please comment more in the main text on application of the method when the expression profile of a sample is a mixture of multiple distributions, which would not be exponential family but commonly encountered in single cell expression data. (5) In application to EGF stimulation dataset, four markers known responding to the simulation have been selected. Will presence of irrelevant markers affect the method’s performance? (6) Page 5, Line 172 and supplementary text Figure A, F. Please indicate the measure of performance and add labels to the y-axis. (7) Page 10, Line 344~345, please denote explicitly log q_i,j = log (inner product of P(x, theta^P), Q(x, theta^Q)). (8) Supplement Page 3, Figure A. The order of figures and the legend description is not consistent. It should be “2D, Random, 1D, Mixture” (9) Supplement Page 4, Line 5 in main text. Correct “… a larger a value of…” to “a larger value of …” (10) Supplement Page 5, Figure C. What is the x-axis in the plots and why is its support [0,1]? Please also label the y-axis. Reviewer #2: A surely useful algorithm with a few practical shortcomings: 1) How does this work complement or expand on other algorithms offering similar approaches but more complex (RNA) data sets, for example Barkas, Nature Methods Aug. 2019? 2) The authors discuss that their current workflow only works on relatively low dimensional data. Wetlab methods move away from low dimension towards more complex data, such as scRNAseq or high dimensional maps of tissues or mass cytometry of complex blood and tissue samples. In order for this work to be applicable to a broader public the authors must use more complex data and also combine their analysis with dimension reduction methods such as UMAP (Uniform Manifold Approximation and Projection). UMAP runs very fast and could address many performance issues mentioned. Also UMAP, controversially to SPADE or the herein used trees, keeps single cells while giving the data a direction in form of population development or development over time. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Carsten Krieg, PhD; Department of Immunology & Dermatology, Medical University of South Carolina, SC 29425 [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Decomposition of a set of distributions in extended exponential family form for distinguishing multiple oligo-dimensional marker expression profiles of single-cell populations and visualizing their dynamics PONE-D-20-01313R1 Dear Dr. Yamada, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Alan D Hutson Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Most of my concerns have been addressed by the authors’ careful revision. However, the authors clarified that the proposed method can only be applied to relatively low dimensional single cell expression profiles. Therefore, my major concern still remains in that the method’s application in its current form is quite limited, even for data sets with moderate number of variables. In addition, the authors commented that "it is necessary to select only a few important markers for high-dimensional CyTOF and scRNA-seq data", but this is not always possible for complex data sets. Although the proposed method is interesting and may be significantly improved by combination with other dimension reduction methods as the other Reviewer suggested, it still requires further development. Therefore, based on the current form of this work, I would recommend rejection. Reviewer #2: The authors have explained their incentives, pointed out the limitations of their approach, and addressed all my questions. Thank you. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
| Formally Accepted |
|
PONE-D-20-01313R1 Decomposition of a set of distributions in extended exponential family form for distinguishing multiple oligo-dimensional marker expression profiles of single-cell populations and visualizing their dynamics Dear Dr. Yamada: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Alan D Hutson Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .